Replies to post #148143 on Amarin Corp Plc (AMRN)

[jessellivermore]

Welcome aboard deut8

Huntington's (I'm not an expert) is a genetic disorder. Although systemic inflammation is like the accelerator in your car and speeds up all processes...It is unlikely to be of great value in Huntington's.

I would suggest you research CRISPR therapeutics. CRISPR holds the possibility of removing hereditary mistakes in the genetic code or adding nucleotide sequences in situations where they are missing...

I can't say this is the answer...but logic suggest it is...

Good luck...

":>) JL

[couldbebetter]

deut8-18, You may be aware of AMRN's failed trial on Huntington's,
However, it was "trending" toward effectiveness. The company used
what we would say is a very low doseage for that trial. Perhaps at a
substantially higher dose Vascepa would have more of an impact on
the disease. If I knew of anyone who was at risk for this disease
I would encourage them to get on 4 grams of Vascepa per day...and
up to 6 grams if they had the disorder. (At least until or unless
something proven comes along.) A high school friend of mine died at
far too young an age from this...I hope a cure is found.